Rationale Unblinded studies have shown improvements in airway hyper-responsiveness (AHR) with chronic nadolol in steroid naïve asthmatics. Objective To assess the effects of chronic non-selective beta-blockade as add on to inhaled corticosteroids (ICS) in asthmatics. Methods A double-blind randomised placebo controlled crossover trial of propranolol in mild-to-moderate asthmatics receiving ICS was performed. Participants underwent a six to eight week dose titration of propranolol or placebo as tolerated to a maximum of 80mg per day. Tiotropium was given for the first four to six weeks of each treatment period. Measurements Primary outcome was methacholine challenge. Secondary outcomes included histamine challenge, pulmonary function, mini-a...
Background: Airway inflammation plays a central role in the pathogenesis of asthma, even in the mild...
BACKGROUND: The role of long-acting, inhaled beta2-agonists in treating asthma is uncertain. In a do...
Introduction: beta-Blockers are known to worsen FEV1 and airway hyperresponsiveness (AHR) in patient...
Rationale Unblinded studies have shown improvements in airway hyper-responsiveness (AHR) with chroni...
Objectives: The aim of this study was to evaluate the effects of non-bronchoconstrictive doses of pr...
Bente Arboe, Charlotte Suppli UlrikDepartment of Pulmonary Medicine, Hvidovre Hospital and Universit...
The murine asthma model shows that switching off airway ß2 receptors with an inverse agonist may con...
Background beta-Antagonists have recently been proposed for the treatment of chronic asthma; however...
Beta-adrenergic blocking agents (abbreviated as beta-blockers) have been used for treating various c...
Background - Propranolol inhalation provocation tests are used to measure indirect airways responsiv...
Background: ß-Antagonists have recently been proposed for the treatment of chronic asthma; however, ...
Background: Airway inflammation plays a central role in the pathogenesis of asthma, even in the mild...
BACKGROUND: The role of long-acting, inhaled beta2-agonists in treating asthma is uncertain. In a do...
Introduction: beta-Blockers are known to worsen FEV1 and airway hyperresponsiveness (AHR) in patient...
Rationale Unblinded studies have shown improvements in airway hyper-responsiveness (AHR) with chroni...
Objectives: The aim of this study was to evaluate the effects of non-bronchoconstrictive doses of pr...
Bente Arboe, Charlotte Suppli UlrikDepartment of Pulmonary Medicine, Hvidovre Hospital and Universit...
The murine asthma model shows that switching off airway ß2 receptors with an inverse agonist may con...
Background beta-Antagonists have recently been proposed for the treatment of chronic asthma; however...
Beta-adrenergic blocking agents (abbreviated as beta-blockers) have been used for treating various c...
Background - Propranolol inhalation provocation tests are used to measure indirect airways responsiv...
Background: ß-Antagonists have recently been proposed for the treatment of chronic asthma; however, ...
Background: Airway inflammation plays a central role in the pathogenesis of asthma, even in the mild...
BACKGROUND: The role of long-acting, inhaled beta2-agonists in treating asthma is uncertain. In a do...
Introduction: beta-Blockers are known to worsen FEV1 and airway hyperresponsiveness (AHR) in patient...